title: Virtual drug discovery: beyond computational chemistry?
abstract: This editorial looks at how a fully integrated structure that performs all aspects in the drug discovery process, under one company, is slowly disappearing. The steps in the drug discovery paradigm have been slowly increasing toward virtuality or outsourcing at various phases of product development in a company's candidate pipeline. Each step in the process, such as target identification and validation and medicinal chemistry, can be managed by scientific teams within a 'virtual' company. Pharmaceutical companies to biotechnology start-ups have been quick in adopting this new research and development business strategy in order to gain flexibility, access the best technologies and technical expertise, and decrease product developmental costs. In today's financial climate, the term virtual drug discovery has an organizational meaning. It represents the next evolutionary step in outsourcing drug development.
authors: ch. des Aulx 18, 1228 Plan-les-Ouates, Switzerland;  +41 0 22 884 8300 ;  fgilardoni@gmail.com.
authors: Francois
authors: F
authors: Gilardoni
authors: Anthony C
authors: AC
authors: Arvanites